Generic Name and Formulations:
Ketorolac tromethamine 0.45%; oph soln; preservative-free.
Indications for ACUVAIL:
Ocular pain and inflammation after cataract surgery.
1 drop in the affected eye twice daily beginning 1 day prior to surgery, continue on day of surgery and through first 2 weeks post-op. Concomitant other topical ophthalmics (eg, alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, mydriatics): administer at least 5 minutes apart.
Do not administer while wearing contacts. Aspirin/NSAID sensitivity. Asthma. Bleeding tendencies. Complicated or repeated ocular surgeries. Corneal defects/denervation. Ocular surface diseases. Diabetes. Rheumatoid arthritis. May delay wound healing. Monitor cornea; discontinue if corneal epithelial breakdown occurs. Pregnancy (Cat.C): avoid in late pregnancy. Nursing mothers.
Concomitant topical steroids may increase potential for healing problems.
Increased intraocular pressure, conjunctival hyperemia and/or hemorrhage, corneal edema, ocular pain, headache, tearing, blurred vision; keratitis, increased ocular bleeding (including hyphemas).
Single-use vials (0.4mL)—30
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke
- Opioid Use Down With 'Enhanced Recovery After Surgery' Program
- Popular Heroin Inhalation Method Tied to Leukoencephalopathy
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL